EQL PHARMA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.3 SEK | +0.70% |
|
+1.41% | +29.64% |
| 04-22 | EQL Pharma AB Announces Mellozzan Launched in Germany and Austria | CI |
| 02-13 | EQL Pharma AB Provides Sales Guidance for the Year 2023/24 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Drug Retailers
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 115M | - | - | - | - | ||
| 10.84B | ||||||
| 6.04B | ||||||
| 5.86B | ||||||
| 6.06B | ||||||
| 4.71B |
- Stock Market
- Equities
- EQL Stock
- Charts EQL Pharma AB
- Sector Chart
